Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes
Status:
Completed
Trial end date:
2000-10-01
Target enrollment:
Participant gender:
Summary
To determine in subjects with Type 1 Diabetes Mellitus:
1. Whether glycemic control can be achieved at least as effectively with a) an intensive
insulin regimen involving pre-meal inhaled insulin plus twice daily subcutaneous NPH
insulin as with b) an intensive subcutaneous insulin regimen involving pre-meal regular
insulin plus twice daily NPH, given as 4 injections per day. The treatment regimens
differ only by the route of delivery of the short acting insulin.
2. The toleration and safety of inhaled insulin therapy and its effects after 6months, if
any, on measures of pulmonary function.